Drug maker halts early safety test in healthy men
NCT ID NCT05183360
Summary
This early-stage study aimed to check the safety and see how the experimental drug BI 706321 moves through the bodies of healthy Japanese and Chinese men. The trial was terminated and did not test the drug for any specific disease. It involved 48 healthy male volunteers to gather basic safety and dosing information.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
SOUSEIKAI Sumida Hospital
Tokyo, Sumida-ku, 130-0004, Japan
Conditions
Explore the condition pages connected to this study.